Tucson, AZ, United States of America

Aleksandra Weichsel

USPTO Granted Patents = 9 


Average Co-Inventor Count = 9.4

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2006-2016

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Innovations and Contributions of Aleksandra Weichsel

Introduction

Aleksandra Weichsel is a prominent inventor based in Tucson, Arizona, known for her significant contributions to the field of pharmaceuticals. With a total of nine patents to her name, she has developed innovative compounds that address critical health issues.

Latest Patents

Among her latest patents is the invention of acylamino-substituted fused cyclopentanecarboxylic acid derivatives. These compounds are valuable pharmaceutical active agents, specifically designed as inhibitors of the endothelial differentiation gene receptor 2 (Edg-2, EDG2). This receptor is activated by lysophosphatidic acid (LPA) and is crucial in treating diseases such as atherosclerosis, myocardial infarction, and heart failure. Additionally, she has patented cycloalkane carboxylic acid derivatives that serve as CXCR3 receptor antagonists. These compounds are aimed at the preventive or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines.

Career Highlights

Throughout her career, Aleksandra has worked with notable companies, including Sanofi and Sanofi-Aventis Deutschland GmbH. Her work in these organizations has allowed her to contribute to the development of groundbreaking pharmaceutical solutions.

Collaborations

She has collaborated with esteemed colleagues such as Marcel Patek and Werngard Czechtizky, further enhancing her research and innovation efforts.

Conclusion

Aleksandra Weichsel's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patents not only showcase her expertise but also contribute significantly to advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…